Page | |
F-2 - F-3 | |
F-4 | |
F-5 - F-6 | |
F-7 - F-8 | |
F-9 - F-18 |
June 30,
|
December 31,
|
|||||||||||
Note
|
2025
|
2024
|
||||||||||
Unaudited
|
||||||||||||
ASSETS
|
||||||||||||
CURRENT ASSETS:
|
||||||||||||
Cash and cash equivalents
|
3
|
|
|
|||||||||
Short-term bank deposits
|
4
|
|
|
|||||||||
Trade receivables (net of allowance for credit losses of $
|
|
|
||||||||||
Inventories
|
5
|
|
|
|||||||||
Other accounts receivable and prepaid expenses
|
|
|
||||||||||
Total current assets
|
|
|
||||||||||
LONG-TERM ASSETS:
|
||||||||||||
Severance pay fund
|
|
|
||||||||||
Deferred tax asset, net
|
|
|
||||||||||
Operating lease right-of-use assets
|
|
|
||||||||||
Property and equipment, net
|
|
|
||||||||||
Total long-term assets
|
|
|
||||||||||
Total assets
|
|
|
June 30,
|
December 31,
|
|||||||||||
Note
|
2025
|
2024
|
||||||||||
Unaudited
|
||||||||||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||||||
CURRENT LIABILITIES:
|
||||||||||||
Trade payables
|
|
|
||||||||||
Other accounts payable and accrued expenses
|
|
|
||||||||||
Short-term operating lease liabilities
|
|
|
||||||||||
Total current liabilities
|
|
|
||||||||||
LONG-TERM LIABILITIES:
|
||||||||||||
Accrued severance pay
|
|
|
||||||||||
Long-term operating lease liabilities
|
|
|
||||||||||
Total long-term liabilities
|
|
|
||||||||||
COMMITMENTS AND CONTINGENT LIABILITIES
|
6
|
|
|
|||||||||
SHAREHOLDERS' EQUITY:
|
7
|
|||||||||||
Share capital -
|
||||||||||||
Ordinary shares of NIS
Authorized:
|
|
|
||||||||||
Additional paid-in capital
|
|
|
||||||||||
Foreign currency translation adjustments
|
|
|
||||||||||
Capital reserves
|
|
|
||||||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||||||
Total shareholders' equity
|
|
|
||||||||||
Total liabilities and shareholders' equity
|
|
|
F - 3
|
Note
|
Six months ended June 30,
|
Three months ended June 30,
|
|||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
||||||||||||||||
Unaudited
|
||||||||||||||||||||
Revenues
|
8
|
|
|
|
|
|||||||||||||||
Cost of revenues
|
|
|
|
|
||||||||||||||||
Gross profit
|
|
|
|
|
||||||||||||||||
Operating expenses:
|
||||||||||||||||||||
Research and development, net
|
|
|
|
|
||||||||||||||||
Selling, general and administrative
|
|
|
|
|
||||||||||||||||
Operating income
|
|
|
|
|
||||||||||||||||
Financial income (expense), net
|
(
|
)
|
|
(
|
)
|
|
||||||||||||||
Income before income taxes
|
|
|
|
|
||||||||||||||||
Taxes on income
|
11
|
|
|
|
|
|||||||||||||||
Net income
|
|
|
|
|
||||||||||||||||
|
||||||||||||||||||||
Other comprehensive income (loss):
|
||||||||||||||||||||
Foreign currency translation adjustments
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Total comprehensive income
|
|
|
|
|
||||||||||||||||
|
||||||||||||||||||||
Basic income per ordinary share
|
|
|
|
|
||||||||||||||||
Diluted income per ordinary share
|
|
|
|
|
F - 4
Company's shareholders
|
||||||||||||||||||||||||||||
Ordinary shares
|
Amount
|
Additional paid-in capital
|
Accumulated other comprehensive income (loss)
|
Capital reserves
|
Accumulated deficit
|
Total
|
||||||||||||||||||||||
Balance as of April 1, 2025
|
|
|
|
(
|
)
|
|
|
|
||||||||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Dividend distribution
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||
Exercise of stock options
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Comprehensive income:
|
||||||||||||||||||||||||||||
Foreign currency translation adjustments
|
|
|
||||||||||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance as of June 30, 2025
|
|
|
|
|
|
(
|
)
|
|
Balance as of April 1, 2024
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Exercise of stock options
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Comprehensive income:
|
||||||||||||||||||||||||||||
Foreign currency translation adjustments
|
-
|
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance as of June 30, 2024
|
|
|
|
(
|
)
|
|
(
|
)
|
|
Company's shareholders
|
||||||||||||||||||||||||||||
Ordinary shares
|
Amount
|
Additional paid-in capital
|
Accumulated other comprehensive income (loss)
|
Capital reserves
|
Accumulated deficit
|
Total
|
||||||||||||||||||||||
Balance as of January 1, 2025
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Dividend distribution
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||
Issuance of shares, net
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Exercise of stock options
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Comprehensive income:
|
||||||||||||||||||||||||||||
Foreign currency translation adjustments
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance as of June 30, 2025
|
|
|
|
|
|
(
|
)
|
|
Balance as of January 1, 2024
|
|
|
|
|
|
(
|
)
|
|
||||||||||||||||||||
Share-based compensation
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Issuance of shares, net
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Exercise of stock options
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Comprehensive income:
|
||||||||||||||||||||||||||||
Foreign currency translation adjustments
|
-
|
|
|
(
|
)
|
|
|
(
|
)
|
|||||||||||||||||||
Net income
|
-
|
|
|
|
|
|
|
|||||||||||||||||||||
Balance as of June 30, 2024
|
|
|
|
(
|
)
|
|
(
|
)
|
|
F - 6
Six months ended
June 30,
|
||||||||
2025
|
2024
|
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
Net income
|
|
|
||||||
Adjustments required to reconcile net income to net cash flows provided by operating activities:
|
||||||||
Depreciation
|
|
|
||||||
Financial expenses (income), net
|
|
(
|
)
|
|||||
Share-based compensation
|
|
|
||||||
Changes in deferred income tax assets, net
|
|
|
||||||
Increase (decrease) in employee severance benefits, net
|
|
(
|
)
|
|||||
Decrease (increase) in trade receivables, net
|
(
|
)
|
|
|||||
Decrease (increase) in operating lease right-of-use assets
|
|
|
||||||
Increase (decrease) in operating lease liabilities
|
(
|
)
|
(
|
)
|
||||
Decrease (increase) in other receivables and prepaid expenses
|
|
|
||||||
Decrease (increase) in inventories
|
(
|
)
|
(
|
)
|
||||
Increase (decrease) in trade payables
|
(
|
)
|
(
|
)
|
||||
Increase (decrease) in other liabilities and accrued expenses
|
(
|
)
|
(
|
)
|
||||
Net cash provided by (used in) operating activities
|
(
|
)
|
|
|||||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
Purchase of property and equipment
|
(
|
)
|
(
|
)
|
||||
Withdrawal of (investment in) short-term bank deposits, net
|
|
(
|
)
|
|||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
Exercise of options
|
|
|
||||||
Dividend distribution
|
(
|
)
|
|
|||||
Issuance of shares, net
|
|
|
||||||
Net cash provided by (used in) financing activities
|
(
|
)
|
|
Six months ended
June 30,
|
||||||||
2025
|
2024
|
|||||||
Effect of exchange rate on cash and cash equivalents
|
|
(
|
)
|
|||||
Decrease in cash and cash equivalents
|
(
|
)
|
(
|
)
|
||||
Cash and cash equivalents at the beginning of the year
|
|
|
||||||
Cash and cash equivalents at the end of the year
|
|
|
||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW ACTIVITIES:
|
||||||||
Cash paid during the year for:
|
||||||||
Cash paid for income taxes
|
|
|
||||||
Supplemental Disclosures of non-cash activity:
|
||||||||
Purchase of property and equipment, not yet paid
|
|
|
||||||
Right-of-use assets recognized with corresponding lease liabilities
|
|
|
F - 8
U.S. dollars in thousands (except share and per share data)
NOTE 1:- |
DESCRIPTION OF BUSINESS AND GENERAL
|
a. |
General:
|
- |
Eltek Ltd. ("the Company") was established in Israel in 1970, and its ordinary shares have been publicly traded on the NASDAQ Capital Market ("NASDAQ") since 1997. Eltek Ltd. and its subsidiaries (Eltek USA Inc. and Eltek Europe GmbH) are collectively referred to as "the Company". As of December 31, 2024, Eltek Europe GmbH is inactive.
|
- |
The Company manufactures, markets and sells printed circuit boards ("PCBs"), including high density interconnect, flex-rigid and multi-layered boards. The principal markets of the Company are in Israel, Europe, India and North America.
|
- |
The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom and networking equipment industries, as well as to contract electronic manufacturers.
|
- |
The Company is controlled by Nistec Golan Ltd ("Nistec Golan"). Nistec Golan is controlled indirectly by Mr. Yitzhak Nissan, who owns, indirectly through Nistec Holdings Ltd., all of the shares of Nistec Golan (Nistec Holdings Ltd. and any of its subsidiaries are referred to as "Nistec").
|
b. |
Credit facilities:
|
c. |
Business risks and condition:
|
- |
The Company’s business is subject to numerous risks including, but not limited to, the impact of currency exchange rates (mainly NIS/US$), the Company's ability to implement its sales and manufacturing plans, the impact of Israel’s continuing war against Hamas and Hezbollah, the impact of competition from other companies, the Company's ability to receive regulatory clearance or approval to market its products, changes in regulatory environment, domestic and global economic conditions and industry conditions, and compliance with environmental laws and regulations.
|
F - 9
U.S. dollars in thousands (except share and per share data)
NOTE 1:- |
DESCRIPTION OF BUSINESS AND GENERAL (CONT.)
|
- |
As of June 30, 2025, the Company's working capital amounted to $
|
- |
In October of 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the attacks, Israel’s security cabinet declared war against Hamas and commenced a military campaign. Since the commencement of these events, there have been additional active hostilities, including with Hezbollah in Lebanon, the Houthi movement which controls parts of Yemen, and with Iran. During November 2024, a ceasefire in Lebanon was declared. It is currently unclear how long the war against Hamas in Gaza may continue. It is possible that these hostilities will escalate in the future into a greater regional conflict, and that additional terrorist organizations and countries will actively join the hostilities. As of August 2025, these events have had no material impact on the Company's operations.
|
- |
The Company's commercial insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle East. Although the Israeli government is currently committed to covering the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, the Company cannot assure that this government coverage will be maintained or, if maintained, will be sufficient to compensate fully the damages incurred.
|
NOTE 2:- | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
A. |
Basis of Presentation
|
F - 10
U.S. dollars in thousands (except share and per share data)
NOTE 2:- | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONT.) |
B. |
Use of Estimates
|
C. |
Significant Accounting Policies
|
D. |
Recently Issued Accounting Pronouncements
|
F - 11
U.S. dollars in thousands (except share and per share data)
NOTE 3:- |
CASH AND CASH EQUIVALENTS
|
June 30,
|
December 31,
|
|||||||
2025
|
2024
|
|||||||
Unaudited
|
||||||||
Denominated in U.S. dollars
|
|
|
||||||
Denominated in NIS
|
|
|
||||||
Denominated in Other Currencies
|
|
|
||||||
|
|
NOTE 4:- |
SHORT-TERM BANK DEPOSITS
|
NOTE 5:- |
INVENTORIES
|
June 30,
|
December 31,
|
|||||||
2025
|
2024
|
|||||||
Unaudited
|
||||||||
Raw materials
|
|
|
||||||
Work-in-progress
|
|
|
||||||
Finished goods
|
|
|
||||||
|
|
NOTE 6:- |
COMMITMENTS AND CONTINGENT LIABILITIES
|
a. |
Pledges:
|
F - 12
U.S. dollars in thousands (except share and per share data)
NOTE 6:- |
COMMITMENTS AND CONTINGENT LIABILITIES (CONT.)
|
b. |
Environmental Related Matters
|
NOTE 7:- |
SHAREHOLDERS' EQUITY
|
a. |
Dividend:
|
b. |
Share Option Plan:
|
F - 13
U.S. dollars in thousands (except share and per share data)
NOTE 7:- |
SHAREHOLDERS' EQUITY (CONT.)
|
Number of options
|
Weighted-average exercise
price
|
Weighted- average remaining contractual life
(in years)
|
Aggregate intrinsic
value
(in thousands)
|
|||||||||||||
Outstanding at January 1, 2025
|
|
|
|
|
||||||||||||
Exercised
|
(
|
)
|
|
-
|
-
|
|||||||||||
Forfeited
|
(
|
)
|
|
|||||||||||||
Granted
|
|
|
-
|
-
|
||||||||||||
Outstanding at June 30, 2025
|
|
|
|
|
||||||||||||
Exercisable at June 30, 2025
|
|
|
|
|
NOTE 8:-
|
OPERATING SEGMENTS AND ENTITY WIDE DISCLOSURES
|
a. |
The Company operates as a single operating segment - manufacturing, marketing and sale of printed circuit boards.
|
F - 14
U.S. dollars in thousands (except share and per share data)
NOTE 8:-
|
OPERATING SEGMENTS AND ENTITY WIDE DISCLOSURES (CONT.)
|
a. |
The following table presents information on reportable segment profit for the periods presented:
|
Six months ended
June 30,
|
Three months ended
June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
Unaudited
|
||||||||||||||||
Revenues
|
|
|
|
|
||||||||||||
Less:
|
||||||||||||||||
Raw materials
|
|
|
|
|
||||||||||||
Manufacturing
|
|
|
|
|
||||||||||||
Salaries
|
|
|
|
|
||||||||||||
Depreciation
|
|
|
|
|
||||||||||||
Other segment items*
|
|
|
|
|
||||||||||||
Net profit
|
|
|
|
|
* |
Other segment items consist of other cost items including cost of sales, research and development, selling, general and administrative, tax expenses and finance income.
|
b. |
Revenues by geographic areas:
|
Six months ended
June 30,
|
Three months ended
June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
Unaudited
|
||||||||||||||||
Israel
|
|
|
|
|
||||||||||||
North America
|
|
|
|
|
||||||||||||
Netherlands
|
|
|
|
|
||||||||||||
India
|
|
|
|
|
||||||||||||
Others
|
|
|
|
|
||||||||||||
|
|
|
|
F - 15
U.S. dollars in thousands (except share and per share data)
NOTE 8:-
|
OPERATING SEGMENTS AND ENTITY WIDE DISCLOSURES (CONT.)
|
c. |
Primary industries for which the Company produced PCBs:
|
Six months ended
June 30,
|
Three months ended
June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
Unaudited
|
||||||||||||||||
Defense and aerospace equipment
|
|
|
|
|
||||||||||||
Medical equipment
|
|
|
|
|
||||||||||||
Industrial equipment
|
|
|
|
|
||||||||||||
Distributors, contract electronic manufacturers and others
|
|
|
|
|
||||||||||||
|
|
|
|
NOTE 9 :- |
FAIR VALUE MEASUREMENTS
|
NOTE 10:- |
BASIC AND DILUTED NET EARNINGS PER SHARE
|
Six months ended
June 30,
|
Three months ended
June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
Unaudited
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Profit attributable to Eltek Ltd. shareholders
|
|
|
|
|
||||||||||||
Denominator:
|
||||||||||||||||
Denominator for basic profit per share weighted-average number of shares outstanding
|
|
|
|
|
||||||||||||
Effect of diluting securities: | ||||||||||||||||
Employee share options
|
|
|
|
|
||||||||||||
Denominator for diluted profit per share - adjusted weighted average shares and assumed exercises
|
|
|
|
|
F - 16
U.S. dollars in thousands (except share and per share data)
NOTE 11:- |
TAXES ON INCOME
|
NOTE 12:- |
RELATED PARTY BALANCES AND TRANSACTIONS
|
a. |
Balances with related parties:
|
Six months ended
June 30,
|
Year ended
December 31,
|
|||||||
2025
|
2024
|
|||||||
Unaudited
|
||||||||
Trade accounts receivable
|
|
|
||||||
Trade accounts payable
|
|
|
b. |
Transactions with related parties:
|
Six months ended
June 30,
|
Three months ended
June 30,
|
|||||||||||||||
2025
|
2024
|
2025
|
2024
|
|||||||||||||
Unaudited
|
||||||||||||||||
Revenues
|
|
|
|
|
||||||||||||
Purchases, selling, general and administrative expenses
|
|
|
|
|
F - 17
U.S. dollars in thousands (except share and per share data)
NOTE 12:- |
RELATED PARTY BALANCES AND TRANSACTIONS (CONT.)
|